Estazolam Tablet
Product Images NDC 0591-0745

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Estazolam (NDC 0591-0745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estazolam Structural Formula (Image 1)

Chemical structure of Estazolam, showing a fused benzodiazepine ring system with a chlorine-substituted phenyl ring and an additional fused triazole ring.*

FDA Label Image

1 (Image 2)

Label for Estazolam Tablets, USP 1 mg by Actavis Pharma, Inc. The label shows the product as tablets with 100 count dosage. It includes instructions for dispensing the medication guide and storage conditions at 20° to 25°C. Manufactured in India by Watson Pharma Private Limited, distributed by Actavis Pharma, Inc. The label includes a barcode and the NDC 0591-0744-01.*

FDA Label Image

1 (Image 3)

Label for Estazolam Tablets, USP 2 mg by Actavis Pharma, Inc. The label indicates the product type as Rx only and includes 100 tablets per container. It specifies storage conditions between 20° to 25°C and features a barcode, lot/expiration coding area, and manufacturer details of Watson Pharma Private Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.